(-)-Cevimeline hydrochloride hemihydrate

Supplier MedChemExpress
Product # HY-76772B-5 mg
Pricing 5 mg, USD $3240.0
Biological Activity (-)-Cevimeline hydrochloride hemihydrate ((-)-SNI-2011), a novel muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren's syndrome.
Synonyms (-)-SNI-2011; (-)-AF102B hydrochloride hemihydrate
MWt 244.78
Formula C₁₀H₁₇NOS.HCl.₁/₂H₂O
Feedback